| |
|
|
|
Infinity Pharmaceuticals Inc.  
|
|
1.32 0.03 (0.02%) |
01-15 16:00 |
|
Open: |
1.31 |
Pre close: |
1.29 |
Target:
|
1.61
|
|
High: |
1.3364 |
Low: |
1.285 |
Resistance:
|
1.38
1.61
|
|
Volume: |
340,540 |
Market Cap: |
75M |
Support:
|
1.15
1.00
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.30
 |
MACD |
MACD(12,26):
|
-0.02 |
|
MA(20): |
1.20 |
Signal(12,26,9): |
-0.05 |
|
MA(100): |
1.87  |
Stochastic Oscillator |
%K(14,3):
|
80.70 |
|
MA(250): |
1.97 |
%D(3): |
78.95 |
|
Average Volume(K) |
3-Month: |
56265
|
52-Week |
High:
|
2.92 |
|
10-Days: |
22066 |
Low: |
1.00 |
|
RSI |
RSI(14):
|
52.67 |
Change(%): |
-34.0 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-18.4 |
Shares Out. (M) |
56.87 |
|
EPS Est. Current Year |
-0.920 |
Return on Assets (ttm) |
-15.9 |
Shares Float (M) |
54.05 |
|
EPS Est. Next Year |
-1.500 |
PEG Ratio |
-0.06 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.200 |
Qtrly Rev. Growth |
266.7 |
% Held by Institutions |
59.10 |
|
Forward EPS |
-0.590 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
1.230 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.07 |
|
Profit Margin |
-13.79 |
Operating Cash Flow
(M) |
-19.86 |
P/S |
183093664.00 |
|
Operating Margin |
-52.24 |
Levered Free Cash Flow
(M) |
-16.30 |
P/CF |
-3.78 |
|
|
|
|
|
|
